Racura Oncology Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	20.94	13.67	17.19	21.52	33.54	9.32
Cash & Short-Term Investments	20.94	13.67	17.19	21.52	33.54	9.32
Cash Growth	11.50%	-20.50%	-20.13%	-35.84%	259.79%	438.63%
Other Receivables	-	0.03	0.11	1.7	0.06	0.13
Receivables	0.03	0.03	0.11	1.7	0.06	0.13
Prepaid Expenses	0.26	1.26	0.12	0.32	0.55	1.14
Total Current Assets	21.23	14.96	17.42	23.54	34.15	10.59
Other Intangible Assets	2.39	2.53	2.81	3.09	3.37	3.66
Total Assets	24.77	17.49	20.23	26.64	37.52	14.25
Accounts Payable	0.17	0.46	1.2	0.64	0.83	0.31
Accrued Expenses	0.8	0.97	0.67	0.51	0.58	0.21
Other Current Liabilities	0.18	0.02	-	-	-	-
Total Current Liabilities	1.16	1.45	1.87	1.15	1.42	0.52
Other Long-Term Liabilities	0.04	0.02	0.05	-	-	-
Total Liabilities	1.2	1.48	1.92	1.15	1.42	0.52
Common Stock	81.6	68.49	66.95	61.71	62.02	31.5
Retained Earnings	-66.3	-62.21	-57.42	-43.6	-33.68	-22.47
Comprehensive Income & Other	8.28	9.73	8.78	7.38	7.77	4.69
Shareholders' Equity	23.57	16.01	18.31	25.49	36.11	13.72
Total Liabilities & Equity	24.77	17.49	20.23	26.64	37.52	14.25
Net Cash (Debt)	20.94	13.67	17.19	21.52	33.54	9.32
Net Cash Growth	11.50%	-20.50%	-20.13%	-35.84%	259.79%	438.63%
Net Cash Per Share	0.12	0.08	0.10	0.13	0.22	0.07
Filing Date Shares Outstanding	180.82	173.74	170.39	163.07	159.52	144.4
Total Common Shares Outstanding	180.82	173.74	170.3	163.07	159.52	143.65
Working Capital	20.07	13.51	15.55	22.39	32.73	10.07
Book Value Per Share	0.13	0.09	0.11	0.16	0.23	0.10
Tangible Book Value	21.18	13.48	15.5	22.39	32.73	10.07
Tangible Book Value Per Share	0.12	0.08	0.09	0.14	0.21	0.07